These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 17922234)

  • 1. Mescaline effects on rat behavior and its time profile in serum and brain tissue after a single subcutaneous dose.
    Pálenícek T; Balíková M; Bubeníková-Valesová V; Horácek J
    Psychopharmacology (Berl); 2008 Jan; 196(1):51-62. PubMed ID: 17922234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of sustained cocaine exposure on sensorimotor gating of startle in rats.
    Martinez ZA; Ellison GD; Geyer MA; Swerdlow NR
    Psychopharmacology (Berl); 1999 Mar; 142(3):253-60. PubMed ID: 10208317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opposite effects of 3,4-methylenedioxymethamphetamine (MDMA) on sensorimotor gating in rats versus healthy humans.
    Vollenweider FX; Remensberger S; Hell D; Geyer MA
    Psychopharmacology (Berl); 1999 Apr; 143(4):365-72. PubMed ID: 10367553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperactivity, decreased startle reactivity, and disrupted prepulse inhibition following disinhibition of the rat ventral hippocampus by the GABA(A) receptor antagonist picrotoxin.
    Bast T; Zhang WN; Feldon J
    Psychopharmacology (Berl); 2001 Jul; 156(2-3):225-33. PubMed ID: 11549225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of sustained phencyclidine exposure on sensorimotor gating of startle in rats.
    Martinez ZA; Ellison GD; Geyer MA; Swerdlow NR
    Neuropsychopharmacology; 1999 Jul; 21(1):28-39. PubMed ID: 10379517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detailed pharmacological evaluation of methoxetamine (MXE), a novel psychoactive ketamine analogue-Behavioural, pharmacokinetic and metabolic studies in the Wistar rat.
    Horsley RR; Lhotkova E; Hajkova K; Jurasek B; Kuchar M; Palenicek T
    Brain Res Bull; 2016 Sep; 126(Pt 1):102-110. PubMed ID: 27155360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral, hyperthermic and pharmacokinetic profile of para-methoxymethamphetamine (PMMA) in rats.
    Páleníček T; Balíková M; Rohanová M; Novák T; Horáček J; Fujáková M; Höschl C
    Pharmacol Biochem Behav; 2011 Mar; 98(1):130-9. PubMed ID: 21167195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mescaline: excitatory effects on acoustic startle are blocked by serotonin2 antagonists.
    Davis M
    Psychopharmacology (Berl); 1987; 93(3):286-91. PubMed ID: 3124159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging toxicity of 5,6-methylenedioxy-2-aminoindane (MDAI): Pharmacokinetics, behaviour, thermoregulation and LD50 in rats.
    Páleníček T; Lhotková E; Žídková M; Balíková M; Kuchař M; Himl M; Mikšátková P; Čegan M; Valeš K; Tylš F; Horsley RR
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Aug; 69():49-59. PubMed ID: 27083855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amphetamine dose dependently disrupts prepulse inhibition of the acoustic startle response in rats within a narrow time window.
    Sills TL
    Brain Res Bull; 1999 Mar; 48(4):445-8. PubMed ID: 10357078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered prepulse inhibition in rats treated prenatally with the antimitotic Ara-C: an animal model for sensorimotor gating deficits in schizophrenia.
    Elmer GI; Sydnor J; Guard H; Hercher E; Vogel MW
    Psychopharmacology (Berl); 2004 Jul; 174(2):177-89. PubMed ID: 14985933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prepulse inhibition during withdrawal from an escalating dosage schedule of amphetamine.
    Russig H; Murphy CA; Feldon J
    Psychopharmacology (Berl); 2003 Sep; 169(3-4):340-53. PubMed ID: 12428150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Withdrawal from repeated amphetamine administration leads to disruption of prepulse inhibition but not to disruption of latent inhibition.
    Peleg-Raibstein D; Sydekum E; Russig H; Feldon J
    J Neural Transm (Vienna); 2006 Sep; 113(9):1323-36. PubMed ID: 16362632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of sex and estrous phase to deficits in prepulse inhibition of the startle response induced by ecstasy (MDMA).
    Bubeníková V; Votava M; Horácek J; Pálenícek T
    Behav Pharmacol; 2005 Mar; 16(2):127-30. PubMed ID: 15767849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of testing conditions on the propsychotic action of MK-801 on prepulse inhibition, social behaviour and locomotor activity.
    Gururajan A; Taylor DA; Malone DT
    Physiol Behav; 2010 Jan; 99(1):131-8. PubMed ID: 19931287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic and behavioural profile of THC, CBD, and THC+CBD combination after pulmonary, oral, and subcutaneous administration in rats and confirmation of conversion in vivo of CBD to THC.
    Hložek T; Uttl L; Kadeřábek L; Balíková M; Lhotková E; Horsley RR; Nováková P; Šíchová K; Štefková K; Tylš F; Kuchař M; Páleníček T
    Eur Neuropsychopharmacol; 2017 Dec; 27(12):1223-1237. PubMed ID: 29129557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the hallucinogen psilocybin on habituation and prepulse inhibition of the startle reflex in humans.
    Gouzoulis-Mayfrank E; Heekeren K; Thelen B; Lindenblatt H; Kovar KA; Sass H; Geyer MA
    Behav Pharmacol; 1998 Nov; 9(7):561-6. PubMed ID: 9862081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic and Pharmacodynamic Aspects of Peyote and Mescaline: Clinical and Forensic Repercussions.
    Dinis-Oliveira RJ; Pereira CL; da Silva DD
    Curr Mol Pharmacol; 2019; 12(3):184-194. PubMed ID: 30318013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of gabapentin on sleep-deprivation-induced disruption of prepulse inhibition.
    Kaya-Yertutanol FD; Uzbay İT; Çevreli B; Bolay-Belen H
    Psychopharmacology (Berl); 2020 Oct; 237(10):2993-3006. PubMed ID: 32594186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute dose-dependent effects of mescaline in a double-blind placebo-controlled study in healthy subjects.
    Klaiber A; Schmid Y; Becker AM; Straumann I; Erne L; Jelusic A; Thomann J; Luethi D; Liechti ME
    Transl Psychiatry; 2024 Sep; 14(1):395. PubMed ID: 39349427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.